Margaret Pang

Statistics

Publications

Citations

680

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Margaret Pang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in p38 mitogen-activated protein kinase signaling, pharmacology, and molecular pharmacology.

Publications per year

1998–2009

Publications

The Activation State of p38 Mitogen-Activated Protein Kinase Determines the Efficiency of ATP Competition for Pyridinylimidazole Inhibitor Binding

Betsy Frantz, Tracey Klatt, Margaret Pang et al. · Biochemistry · 1998 · 200 citations

Life Sciences, Biochemistry, Molecular Biology +14

Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase

Nigel J. Liverton, John W. Butcher, Christopher F. Claiborne et al. · Journal of Medicinal Chemistry · 1999 · 196 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pyrroles and other heterocycles as inhibitors of P38 kinase

Stephen E. de Laszlo, Denise M. Visco, Lily Agarwal et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Substituted Imidazoles as Glucagon Receptor Antagonists

Linda L. Chang, Kelly L. Sidler, Margaret A. Cascieri et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

A randomized controlled trial to evaluate the relative efficacy of adding voluntary counseling and testing (VCT) to information dissemination in reducing HIV-related risk behaviors among Hong Kong male cross-border truck drivers

Joseph T. F. Lau, Hi Yi Tsui, Shannon Cheng et al. · AIDS Care · 2009 · 33 citations

Public Health, Health Promotion, Preventive Medicine +17

1–5 of 6